TL;DR
Get comfort and recovery gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Neko Health says it plans to open a second Manhattan clinic in January and a Miami location by the end of the year, with San Francisco and Washington, D.C., also in its pipeline. The company reports that its U.S. waitlist has topped 50,000, but has not released U.S. repeat-booking figures or detailed schedules for all planned sites.
Neko Health plans to expand its U.S. clinic network beyond its first location in New York City, with a second Manhattan clinic scheduled for January and a Miami site due by year-end, according to the company. San Francisco and Washington, D.C., are also in its pipeline. The expansion follows a reported U.S. waitlist of more than 50,000 people, though the company has not disclosed how many have completed scans or booked follow-up visits in the United States.
The company’s first U.S. clinic opened in SoHo last month, according to Athletech News. Before opening, Neko said more than 25,000 New Yorkers had joined its waitlist; it said the total then rose to over 50,000 within two weeks. Those figures are company-reported and describe interest, not completed appointments. Neko did not provide a breakdown by city or say how many people on the list will become customers.
Neko charges $499 for a scan. The noninvasive service combines a 53-biomarker blood panel processed on-site with measurements including blood pressure, body composition, an EKG and other cardiac checks, grip strength and eye pressure. The skin assessment uses visible-light cameras, infrared thermal imaging and depth sensing to identify moles that may warrant closer review. Members discuss findings with a clinician, with the visit taking about an hour, the report said.
The company says it raised $700 million in a Series C led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. The round included technology and celebrity investors, among them Mark Zuckerberg, according to the report. Neko also says customers who need follow-up can be referred to partner providers in New York, including Columbia University Irving Medical Center, Mount Sinai Health System and Schweiger Dermatology, or to their own doctors. It accepts HSA and FSA payments.
A New Model for Paid Screening
The expansion tests whether demand for clinic-based preventive screening can support a chain beyond its first high-profile New York site. Neko’s approach combines several tests and a clinician consultation in one visit, at a price paid directly by customers. That places it between routine care and more expensive private health assessments, but the company has not released data showing how many U.S. customers follow through after joining the waitlist.
The service is not a substitute for primary care or established cancer-screening programs. Its relevance for readers depends on both access and scope: a $499 visit is a significant out-of-pocket expense, and the scan does not cover many conditions people may associate with a general health check. The locations and customer response will show whether the model can attract sustained demand outside SoHo.
As an affiliate, we earn on qualifying purchases.
What the Neko Scan Covers
Neko was co-founded by Spotify co-founder Daniel Ek and chief executive Hjalmar Nilsonne. It has operated in Sweden and the United Kingdom, where the company says more than 100,000 people have been scanned. Neko reports that 75% of members in those markets book and prepay for another scan before leaving, and that 80% book a third after their second. Those figures are from Europe; the company has not shared comparable U.S. rebooking data.
The company draws a clear boundary around its screening. Neko says its service is not an MRI or CT scan and does not create images of internal organs. It does not screen for breast, colon, lung, prostate or most other cancers. While it can flag signs associated with coronary artery disease, Neko says it cannot diagnose or rule out that disease. The company’s service therefore differs from whole-body MRI providers such as Prenuvo.
The launch comes as consumers report concern about health-care affordability and place emphasis on wellness, but those broad trends do not establish why people joined Neko’s list or whether they will pay for a scan. The company’s U.S. expansion is also entering a market where gyms, testing companies and longevity providers offer other forms of paid health assessment.
“What we’ve seen is unmistakable: when people can see their health clearly and know what to do about it, they get healthier.”
— Hjalmar Nilsonne, Neko Health co-founder and CEO, quoted when the New York clinic opened
As an affiliate, we earn on qualifying purchases.
U.S. Demand and Site Timelines
The company has not published U.S. scan totals, attendance rates, repeat-booking figures or clinical outcomes. A waitlist count does not establish how many people will pay for or receive a scan. The timing for San Francisco and Washington, D.C., remains unspecified, and the report does not give an exact opening date for the Miami clinic beyond a year-end target.
It is also unclear how the clinics will handle findings that need medical follow-up, how many customers will require referrals, or what care those referrals lead to. Neko’s stated screening limits mean a clear result from its scan should not be read as ruling out cancers it does not test for or diseases it cannot diagnose.
As an affiliate, we earn on qualifying purchases.
Openings and U.S. Results
The next stated milestones are the second Manhattan clinic in January and the Miami location by the end of the year. Neko has named San Francisco and Washington, D.C., as planned markets but has not supplied opening dates. The company’s subsequent announcements and actual clinic openings should clarify the pace and geography of its rollout.
Further U.S. information to watch includes how many people complete scans, whether customers return, and what the company reports about referrals and follow-up. Until those figures are available, the waitlist signals reported interest rather than demonstrated long-term demand or health impact.
As an affiliate, we earn on qualifying purchases.
Key Questions
Where is Neko Health expanding in the United States?
Neko says it plans a second Manhattan clinic in January and a Miami location by year-end. San Francisco and Washington, D.C., are also in its pipeline, but no opening dates were provided for those cities.
How much does a Neko Health scan cost?
The scan at the New York clinic costs $499, according to the report. Neko says it accepts HSA and FSA payments.
What does the scan include?
The visit includes skin imaging, blood pressure and body-composition checks, an EKG and other cardiac measurements, grip strength and eye pressure tests, plus a 53-biomarker blood panel. A clinician reviews the findings with the customer.
Does Neko’s scan detect cancer or replace a doctor?
No. Neko says the scan does not screen for breast, colon, lung, prostate or most other cancers, and it does not diagnose or rule out coronary artery disease. The company says customers needing follow-up can be referred to providers or consult their own doctors; the service is not a replacement for routine medical care.
How many people have received a scan in the United States?
The report gives a U.S. waitlist figure of more than 50,000, as reported by Neko, but does not state how many people have completed scans. The company has not released U.S. repeat-booking figures.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
